Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
KUNLUN ENERGY
00135
| (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | (Q2)Jun 30, 2021 | (Q1)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -111.53%-1.8M | -100.49%-88.73K | 52.56%3.82M | 39.29%-2.19M | -147.91%-3.33M | 90,536.54%15.57M | 2,106,150.58%18.03M | 29,591.56%2.5M | -48,745.43%-3.62M | -287,230.13%-1.34M |
| Net income from continuing operations | 49.83%-3.17M | -391.10%-1.07M | 299.08%5.43M | 45.74%-2.67M | -91.01%-4.85M | -7,139.97%-6.31M | -327.61%-218.74K | 4,929.84%1.36M | -66,258.69%-4.91M | -542,880.56%-2.54M |
| Operating gains losses | ---188.8K | ---204K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | ---- | ---- | ---- | -2,758.72%-41.48K | 7,400.00%45.83K | ---- | ---- | ---- | --1.56K | --611 |
| Asset impairment expenditure | --0 | ---- | ---- | ---- | ---- | --17.12M | ---- | ---- | ---- | ---- |
| Unrealized gains and losses of investment securities | --0 | --0 | ---4.2K | -99.11%7.35K | -100.42%-3.15K | --1.58M | --0 | --0 | --830.05K | --745.8K |
| Remuneration paid in stock | -51.94%1.13M | -83.02%181.2K | -252.32%-821.23K | 0.49%740.4K | --1.03M | --2.34M | --1.07M | --539.13K | --736.77K | --0 |
| Other non cashItems | -110.45%-121.47K | -287.36%-26.58K | ---157.76K | ---12.27K | --75.15K | --1.16M | --14.19K | --0 | ---- | ---- |
| Change In working capital | 277.71%554.51K | 1,977.40%1.03M | -204.20%-633.38K | 84.25%-223.59K | -16.32%376.57K | -545.99%-312.02K | -0.96%49.82K | --607.87K | ---1.42M | --450.03K |
| -Change in receivables | 346.49%110.79K | 123.08%19.26K | -51.36%39.41K | 613.27%97.92K | -94.98%-45.8K | -8,678.71%-44.95K | -669.34%-83.41K | --81.03K | ---19.08K | ---23.49K |
| -Change in prepaid assets | 173.42%305.89K | -75.13%98.31K | -141.89%-252.16K | 102.19%28.16K | 434.40%431.57K | ---416.62K | --395.35K | --601.9K | ---1.28M | ---129.06K |
| -Change in payables and accrued expense | -7.83%137.83K | 449.97%917.33K | -460.37%-420.64K | -201.84%-349.67K | -101.53%-9.2K | 112.20%149.55K | -1,031.19%-262.12K | ---75.06K | ---115.85K | --602.57K |
| Cash from discontinued investing activities | 78.62%-5.89M | 95.06%-1.1M | 9.35%-4.73M | -27.56M | -22.35M | -5.21M | ||||
| Operating cash flow | 35.89%-7.69M | 72.41%-1.19M | 66.58%-905.67K | 37.59%-2.26M | -147.91%-3.33M | -69,537.17%-11.99M | -505,258.60%-4.32M | -31,802.10%-2.71M | -48,745.43%-3.62M | -287,230.13%-1.34M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -70.26%726.27K | 73,100.00%1.46K | -64.67%724.81K | -87.10%51.7K | -419.30%-51.7K | 2.44M | 2 | 2.05M | 400.67K | -9.96K |
| Net PPE purchase and sale | ---- | ---- | ---- | 1,981.91%51.7K | -419.30%-51.7K | ---- | ---- | ---- | ---2.75K | ---9.96K |
| Net business purchase and sale | -66.50%682.97K | --0 | -58.24%682.97K | ---- | ---- | --2.04M | --2 | --1.64M | ---- | ---- |
| Net investment purchase and sale | --0 | --0 | ---- | ---- | ---- | --403.42K | --0 | ---- | ---- | ---- |
| Net other investing changes | --43.3K | --1.46K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | -966.76%-214.14K | -4,221.80%-119.76K | -2,010.42%-365.17K | -20.07K | -2.77K | -17.3K | ||||
| Investing cash flow | -78.86%512.13K | -4,172.05%-118.29K | -82.32%359.64K | -19.52%322.48K | -419.30%-51.7K | --2.42M | ---2.77K | --2.03M | --400.67K | ---9.96K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -95.41%685.19K | -18.29%-476.97K | 116.65%65.94K | -90.52%1.21M | -103.77%-112.61K | 1,063.69%14.94M | -132.00%-403.22K | -396.16K | 12.75M | 2.99M |
| Net issuance payments of debt | -105.50%-163.44K | 76.09%-96.42K | 116.65%65.94K | -112.49%-115.08K | -100.63%-17.88K | --2.97M | ---403.22K | ---396.16K | --921.72K | --2.85M |
| Net common stock issuance | -92.91%848.63K | ---380.55K | --0 | -89.61%1.23M | --0 | 49,776.93%11.97M | --0 | --0 | --11.83M | --140.51K |
| Net other financing activities | ---- | ---- | ---- | ---- | ---94.73K | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | 2,485.09%462.21K | 2,425.05%406.58K | 5,364.22%99.6K | -19.38K | -17.49K | -1.89K | ||||
| Financing cash flow | -92.31%1.15M | 83.27%-70.39K | 141.59%165.54K | -90.87%1.16M | -103.77%-112.61K | 1,062.18%14.92M | -133.39%-420.7K | ---398.05K | --12.75M | --2.99M |
| Net cash flow | ||||||||||
| Beginning cash position | 419.12%6.58M | -90.74%1.04M | -86.14%1.76M | 10.05%3.19M | 419.12%6.58M | --1.27M | 147,440.43%11.27M | --12.69M | --2.9M | --1.27M |
| Current changes in cash | -212.60%-6.03M | 70.90%-1.38M | 64.56%-380.49K | -108.06%-769.01K | -313.97%-3.5M | 322.62%5.35M | -476.79%-4.74M | ---1.07M | --9.54M | 349,427.14%1.63M |
| Effect of exchange rate changes | -128.44%-101.44K | 1,346.79%784.01K | 5.19%-336.08K | -359.74%-664.67K | --115.3K | ---44.4K | --54.19K | ---354.49K | --255.9K | --0 |
| End cash Position | -93.21%446.39K | -93.21%446.39K | -90.74%1.04M | -86.14%1.76M | 10.05%3.19M | 419.12%6.58M | 419.12%6.58M | 147,440.43%11.27M | 161,400.38%12.69M | 620,106.84%2.9M |
| Free cash from | 35.89%-7.69M | 72.41%-1.19M | 66.42%-905.67K | 39.07%-2.2M | -149.91%-3.39M | -69,537.17%-11.99M | -505,258.60%-4.32M | -31,652.55%-2.7M | -48,782.55%-3.62M | -289,357.26%-1.35M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.